Silent Stroke During TAVR and Early Cognitive Impairment

Silent stroke is common after transcatheter aortic valve replacement (TAVR). Co-morbidities such as diabetes or chronic renal failure, as well as procedural factors such as pre-dilation, increase the risk of silent stroke.

Es un hecho: la protección cerebral en TAVI logró demostrar que reduce el stroke y la muerte

While many events of silent stroke have an early effect on cognition, it is necessary to learn whether the impairment is sustained over time—specially in lower-risk populations with longer life expectancy. Cerebral protection devices do not seem to significantly reduce the issue.

In this paper, a systematic search of every study reporting the incidence of silent cerebral lesions detected in post-TAVR diffusion MRI was conducted. The amount of new silent lesions, baseline characteristics of patients, and incidence of early cognitive impairment were evaluated.

A total of 39 studies with said characteristics were identified. They included over 2000 patients who met inclusion criteria and had undergone a diffusion MRI after TAVR.

Surprisingly, 1601 patients experienced at least one new silent cerebral lesion. However, the clinical significance of these new lesions only reached 3%.

The analysis of co-morbidities analysis showed that diabetes, chronic renal failure, evaluations with 3T equipment, and pre-dilation were associated with a higher risk of silent imaging.


Read also: Short Therapy and Monotherapy, Plenty of Evidence.


Prevalence of early cognitive impairment at one-year rose from 16% at 10.0 ± 6.3 days to 26% at 6.1 ± 1.7 months. The number of new silent cerebral lesions was also linked to early cognitive impairment, evidencing an association between the mean number of silent lesions and the incidence of impairment.

Using different cerebral protection devices during the procedure seems to reduce the number of lesions, but not the incidence of cognitive impairment.

Conclusion

Post-TAVR silent stroke is a common event. Co-morbidities such as diabetes and pre-dilation increase the chances of its occurrence.

While more new lesions negatively impact impairment, longer-term follow-up is needed to expand in younger populations. The use of brain protection devices does not seem to be clinically useful.

ehab002free

Original Title: Silent brain infarcts and early cognitive outcomes after transcatheter aortic valve implantation: a systematic review and meta-analysis.

Reference: Kei Woldendorp et al. European Heart Journal (2021) 42, 1004–1015 doi:10.1093/eurheartj/ehab002.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Coronary revascularization before TAVI: prior PCI or conservative management?

The coexistence of coronary artery disease (CAD) in patients with severe aortic stenosis undergoing TAVI is common, with a reported prevalence ranging from 30%...

CRT 2026 | TAVI-CLOSE Trial: Dual Suture vs Suture + Plug for Vascular Closure After Transfemoral TAVI

The transfemoral approach is the predominant strategy for transcatheter aortic valve implantation (TAVI). Although vascular complications are currently less frequent, they remain relevant determinants...

CRT 2026 | NAVITOR IDE: Hemodynamic Outcomes and 5-Year Durability of an Intra-Annular Self-Expanding Transcatheter Aortic Valve

As TAVI expands into younger populations and patients with lower surgical risk, prosthesis durability has become a key aspect of long-term management. The NAVITOR...

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...